Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Spectral AI, Inc. - Warrants
(NQ:
MDAIW
)
0.1085
-0.0415 (-27.67%)
Streaming Delayed Price
Updated: 3:59 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Spectral AI, Inc. - Warrants
< Previous
1
2
3
Next >
Spectral AI Announces DeepView SnapShot® M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research
Today 8:00 EST
Spectral AI is dedicated to supporting the U.S. Military, first responders, and healthcare providers in delivering life-saving diagnostics in the most critical environments.
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
November 19, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Announces 2024 Third Quarter Financial Results
November 06, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
November 06, 2024
Strategic Spinoff Aims to Unlock IP Value and Sharpen Focus on AI Medical Diagnostics
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers
October 30, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
October 23, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors
October 14, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Completes Proof of Concept for Wound Measurement Technology
October 03, 2024
Provides Clinicians with Superior Wound Size Measurement Information that Improves Patient Treatment Decisions
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
September 24, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication
September 17, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
American Burn Association Study Highlights Inequities in Access to Specialized Burn Care
September 10, 2024
Spectral AI’s DeepView® System Designed to Provide Equity in Burn Care Access While Optimizing Healthcare Resources
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®
September 05, 2024
Project Funding Exceeds $7.0 Million
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI to Participate in Upcoming Investor Conferences
August 28, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study
August 27, 2024
Milestone Achievement Advances Commercialization Timeline for DeepView™ System for Burn Indication
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Announces Podium Presentation at BBA / ISBI Joint Conference Assessing Burn Wound Severity Using Multispectral Imaging and Artificial Intelligence
August 19, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Announces 2024 Second Quarter Financial Results
August 12, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M® for Military Field Use
July 31, 2024
Poster Presentation at 2024 Military Health System Research Symposium
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call
July 29, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of its AI-Driven DeepView System
July 24, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Adds Three New Clinical Trial Sites To Expedite Emergency Department Patient Enrollment
July 23, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Continues Support of Naked Short Selling Inquiry
July 15, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Announces Collaboration with Global Wound Care Company PolyNovo to Introduce DeepView System for Burn Indication to Australian Market
July 08, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Expands Clinical Trial Sites for Pivotal U.S. Burn Study
July 03, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study
July 02, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Joins Russell Microcap® Index
July 01, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Surpasses 90% of Pediatric Enrollment Target in Burn Centers for Pivotal U.S. Burn Study
June 27, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Supports Naked Short Selling Inquiry
June 24, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI to Participate in the Northland Capital Markets Virtual Growth Conference
June 17, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study
June 06, 2024
Total Patient Enrollment of 90 Towards Overall Target of 240
From
Spectral AI, Inc.
Via
GlobeNewswire
Spectral AI Set to Join Russell Microcap® Index
May 29, 2024
From
Spectral AI, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.